BioCatalystWatch
PLYXWorkspace / PLYX / OverviewCompany library
Polaryx Therapeutics, Inc. logo

Polaryx Therapeutics, Inc.

Polaryx Therapeutics, Inc. (PLYX)

Website

Price
Market cap
Next catalystExpected Q4 2026PLX-200 — SOTERIA basket trial · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

PLX-200

PPARα

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

PLX-200

PPARα

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Other pipelines

PLX-300

PPARα

PLX-100

PPARα × RXRα

PreINDP1P2P3FilingApproved
PLX-400

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PLYX PR & News

PR & News

PLYX SEC archive